NO145244C - Analogifremgangsmaate til fremstilling av nye gona-4,9(10)-diener med progestagen-aktivitet - Google Patents

Analogifremgangsmaate til fremstilling av nye gona-4,9(10)-diener med progestagen-aktivitet

Info

Publication number
NO145244C
NO145244C NO772054A NO772054A NO145244C NO 145244 C NO145244 C NO 145244C NO 772054 A NO772054 A NO 772054A NO 772054 A NO772054 A NO 772054A NO 145244 C NO145244 C NO 145244C
Authority
NO
Norway
Prior art keywords
gona
progestagen
activities
preparation
new
Prior art date
Application number
NO772054A
Other languages
English (en)
Norwegian (no)
Other versions
NO772054L (no
NO145244B (no
Inventor
Kurt Ponsold
Michael Huebner
Michael Oettel
Original Assignee
Jenapharm Veb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD7600193348A external-priority patent/DD132497A1/xx
Application filed by Jenapharm Veb filed Critical Jenapharm Veb
Publication of NO772054L publication Critical patent/NO772054L/no
Publication of NO145244B publication Critical patent/NO145244B/no
Publication of NO145244C publication Critical patent/NO145244C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO772054A 1976-06-14 1977-06-13 Analogifremgangsmaate til fremstilling av nye gona-4,9(10)-diener med progestagen-aktivitet NO145244C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD7600193348A DD132497A1 (de) 1976-06-14 1976-06-14 Verfahren zur herstellung von neuen gona-4,9(10)-dienen

Publications (3)

Publication Number Publication Date
NO772054L NO772054L (no) 1977-12-15
NO145244B NO145244B (no) 1981-11-02
NO145244C true NO145244C (no) 1982-02-10

Family

ID=5504816

Family Applications (2)

Application Number Title Priority Date Filing Date
NO772054A NO145244C (no) 1976-06-14 1977-06-13 Analogifremgangsmaate til fremstilling av nye gona-4,9(10)-diener med progestagen-aktivitet
NO811764A NO146574C (no) 1976-06-14 1981-05-25 Kjemiske forbindelser med svangerskaps- resp. drektighetshindrende virkning

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO811764A NO146574C (no) 1976-06-14 1981-05-25 Kjemiske forbindelser med svangerskaps- resp. drektighetshindrende virkning

Country Status (18)

Country Link
US (1) US4248790A (xx)
JP (1) JPS5312849A (xx)
BE (1) BE855617A (xx)
BR (1) BR7703832A (xx)
CH (1) CH635594A5 (xx)
DE (1) DE2718872A1 (xx)
DK (1) DK259477A (xx)
ES (1) ES461987A3 (xx)
FI (1) FI57113C (xx)
FR (1) FR2393008A1 (xx)
GB (1) GB1524917A (xx)
HU (1) HU177333B (xx)
IT (1) IT1116654B (xx)
MX (1) MX4685E (xx)
NL (1) NL187167C (xx)
NO (2) NO145244C (xx)
SE (1) SE426833B (xx)
YU (1) YU39804B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201091B (en) 1985-12-26 1990-09-28 Mitsubishi Chem Ind Process for producing gonatriene derivatives and pharmaceutical compositions comprising same
JPS6322598A (ja) * 1986-07-14 1988-01-30 Mitsubishi Chem Ind Ltd ゴナトリエン誘導体およびその製造法
JPS6372627A (ja) * 1986-09-17 1988-04-02 Mitsubishi Kasei Corp 子宮内膜症治療薬
JPH0780335B2 (ja) * 1989-11-20 1995-08-30 富士通株式会社 リボンカセット
ATE215826T1 (de) * 1993-11-19 2002-04-15 Jenapharm Gmbh Karzinostatisches mittel für hormontherapie, das dienogest als wirksamer bestandteil enthält
ES2120267T3 (es) * 1995-12-22 1998-10-16 Jenapharm Gmbh Nuevos derivados de 17alfa-cianometilestra-4,9-dieno, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
HUP0501132A2 (en) * 2005-12-05 2007-06-28 Richter Gedeon Nyrt 17-alpha-cyanomethyl-17betha-hydroxyestra-4,9-diene-3-one of high purity and process for its production
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
ATE536362T1 (de) * 2009-05-22 2011-12-15 Heyl Chem Pharm Verfahren zur synthese von dienogest aus estron-3-methylether
WO2011132045A2 (en) 2010-04-20 2011-10-27 Lupin Limited Process for the preparation of dienogest substantially free of impurities
CN112724191B (zh) * 2020-12-30 2022-11-15 上海汇伦医药股份有限公司 一种地诺孕素的精制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502699A (en) * 1962-05-15 1970-03-24 Herchel Smith Novel delta4,9-3-ketosteroids and method for preparing same
DE1214223B (de) * 1962-11-22 1966-04-14 Roussel Uclaf Verfahren zur Herstellung von Hydroxy-hydroxymethyl-steroiden
US3624110A (en) * 1964-08-03 1971-11-30 Herchel Smith 13-ethylgona-4,9-dienes
GB1130881A (en) * 1964-08-06 1968-10-16 Merck & Co Inc Steroidal-í¸-dien-3-ones and derivatives thereof
FR2031807A5 (en) * 1969-02-07 1970-11-20 Jenapharm Veb 17a-subst estratrienes
US3931154A (en) * 1973-07-07 1976-01-06 Schering Aktiengesellschaft Process for the preparation of steroid oxiranes
US4029648A (en) * 1976-01-15 1977-06-14 Veb Jenapharm Process of making gona-1,3,5(10),9(11)-tetraenes

Also Published As

Publication number Publication date
JPS5312849A (en) 1978-02-04
BR7703832A (pt) 1978-04-25
NL187167C (nl) 1991-06-17
HU177333B (en) 1981-09-28
YU39804B (en) 1985-04-30
ES461987A3 (es) 1978-06-01
DK259477A (da) 1977-12-15
CH635594A5 (de) 1983-04-15
US4248790A (en) 1981-02-03
NO772054L (no) 1977-12-15
DE2718872A1 (de) 1977-12-22
JPS616838B2 (xx) 1986-03-01
SE426833B (sv) 1983-02-14
FR2393008B1 (xx) 1982-05-07
BE855617A (fr) 1977-12-13
MX4685E (es) 1982-07-30
NO811764L (no) 1977-12-15
IT1116654B (it) 1986-02-10
FI771865A (xx) 1977-12-15
NO145244B (no) 1981-11-02
NO146574B (no) 1982-07-19
FR2393008A1 (fr) 1978-12-29
NO146574C (no) 1982-10-27
DE2718872C2 (xx) 1987-12-10
SE7706835L (sv) 1978-01-15
NL7706465A (nl) 1977-12-16
FI57113B (fi) 1980-02-29
GB1524917A (en) 1978-09-13
YU146577A (en) 1982-06-30
FI57113C (fi) 1980-06-10
NL187167B (nl) 1991-01-16

Similar Documents

Publication Publication Date Title
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO145244C (no) Analogifremgangsmaate til fremstilling av nye gona-4,9(10)-diener med progestagen-aktivitet
DK467377A (da) Fremgangsmaade til fremstilling af 1,4,3,6-dianhydro-d-glucitol-2-nitrat.
NO148921C (no) Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO145433C (no) Fremgangsmaate til fremstilling av 1,3-butadien.
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
DK148538C (da) Analogifremgangsmaade til fremstilling af 2,3-substituerede 4-pyroner
DK158353C (da) Analogifremgangsmaade til fremstilling af 3, 6, 7, 8-substituerede s-triazoloe4,3-baapyridaziner.
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
NO158743C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser.
DK143757C (da) Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener
DK152120C (da) Analogifremgangsmaade til fremstilling af 4-(2-acyloxy-3-tert.butylaminopropoxy)-indolderivater
SE409864B (sv) Forfarande for framstellning av 4-imino-1,3-diazabicyklo(3.1.0)hexan-2-on
DK153479C (da) Analogifremgangsmaade til fremstilling af 1,4-benzodiazepin-2-on-derivater
DK147070C (da) Analogifremgangsmaade til fremstilling af 13,14-dehydro-11-deoxy-prostaglandiner
NO801613L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO154840C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte 2-amino-3,4-dihydropyridinderivater.
NO158737C (no) Analogifremgangsmaate til fremstilling av nye 3-alkoksy-6-alkylidenhydrazinpyridaziner.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK145781C (da) Analogifremgangsmaade til fremstilling af ditiino(1,4)(2,3-c)pyrrolderivater
NO145239C (no) Analogifremgangsmaate ved fremstilling av analgetisk virksomme 2,9-dioxatricyclo-(4.3.1.0 3,7)-decaner
DK139586B (da) Analogifremgangsmåde til fremstilling af 2,2-dimethyl-19-nor-pregn-4-en-3,20-dioner.
NO144966C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme 1,6-anhydro-beta-d-heksopyranosederivater